Novel Clinical Research Center, LLC

01/21/2021

Si usted padece de Migraña o dolores de cabeza crónicos y desea participar en un estudio de investigación, llámenos al 786-773-2737

If you suffer from Migraine or chronic headaches and you have considered participating in a research study, please call us at 786-773-2737

11/23/2020

Llámenos al 786-773-2737

We are conducting clinical trials in patients with Scelorderma (Systemic Sclerosis) and Migraine. If you are interested in participating, please call us at 786-773-2737.

10/03/2020

CGRP migraine treatment may be the migraine relief you've been looking for. Many people with chronic migraine have a high level of a substance called CGRP in their blood. Newly approved injectable treatment lowers CGRP levels and helps reduce pain and stop migraine attacks.

08/02/2020

Find out more about Novel Clinical Research by following them on Google

04/17/2020

These results have not been published since two phase III trials are still ongoing at University of Chicago and the data was leaked. Nevertheless, a study published in the New England Journal of Medicine 7 days ago already showed 68% of patients (most of them severe cases) treated with Remdesevir with compassionate use improved. So, there is progress.
Estos resultados no han sido publicados porque todavía los estudios están en fase 3 en University of Chicago. Independientemente de eso, un estudio publicado en New England Journal of Medicine hace 7 días demostró que el 68% de los pacientes tratados con Remdesevir (la mayoría severos) mejoraron.

The outcomes in patients at a Chicago hospital offer only a snapshot of remdesivir’s effectiveness, but are the first clinical data to surface to date.

03/28/2020

Abbott Laboratories said late Friday that it received emergency use authorization from the U.S. Food and Drug Administration for a rapid COVID-19 test....

02/12/2020

Pimavanserin is being studied to assess several key efficacy endpoints, including psychosis, agitation/aggression, and sleep/nighttime behavior.

12/06/2019

SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether...

11/03/2019

Excellent results. Effective treatment option for patients with dementia who suffer hallucinations or delusions.

ACADIA Pharmaceuticals Announces Pivotal Phase 3 HARMONY Trial Stopped Early for Positive Efficacy as Pimavanserin Meets the Primary Endpoint in Patients with Dementia-Related Psychosis - read this article along with other careers information, tips and advice on BioSpace

08/06/2019

This is interesting and indeed could be a game changer. However, a positive test only predicted amyloid positive status in cognitively normal individuals. The study (according to the Neurology green journal) concludes the results "can be used to screen cognitively normal individuals for brain amyloidosis". This is tricky since screening a person with no memory loss for Alzheimer's could have negative consequences for those individuals because there is no effective therapy to slow progression of the disease. However, this blood test could be a useful screening tool for early memory loss and thus, avoid expensive imaging studies. Larger studies are needed.

When combined with age and APOE ε4 status, the blood test is 94% accurate in detecting brain amyloidosis and may be a "game changer" for the field.

03/10/2019

"Diagnóstico de demencia
No existe una prueba diagnostica única que determine si una persona tiene demencia. El diagnostico de Alzheimer y otros tipos de demencia se basan en antecedentes médicos, un examen físico, pruebas de laboratorio y los cambios característicos en el pensamiento y las actividades de la vida diaria. En algunos casos, el médico primario puede diagnosticar "demencia" y no especificar el tipo. Si esto ocurre, puede ser necesario ver a un un neurólogo.

Tratamiento de la demencia
El tratamiento de la demencia depende de su causa. En el caso de las demencias mas progresivas, incluida la enfermedad de Alzheimer, no existe una cura ni un tratamiento que detenga su avance. Pero existen tratamientos farmacológicos que pueden mejorar los síntomas temporalmente. Los tratamientos sin medicamentos también pueden aliviar algunos síntomas de la demencia.

Finalmente, para facilitar el camino hacia nuevos tratamientos efectivos para la demencia se necesitan voluntarios urgentemente para participar en más de 180+ estudios y ensayos clínicos en fase de reclutamiento activo sobre el Alzheimer y otros tipos de demencia relacionados"

Si usted desea aprender más de esta enfermedad, su tratamiento y nuevos ensayos clínicos llámenos al (786) 773-2737.

03/02/2019

This article describes common early signs of dementia. Multiple causes of dementia have been described, with Alzheimer's disease being the most common. Other causes of dementia include Stroke, Parkinson's disease, Frontotemporal degeneration (FTD), Lewy body disease, Inflammatory/infectious disorders, Normal Pressure Hydrocephalus (NPH) and vitamin deficiencies (eg. B12 deficiency).

Watching your parents begin to age is a tough spot for most anyone. Of course you just want them to stay young and healthy as long as possible. But there comes a time when you need to tell the normal signs of aging apart from potential problems. But…